The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The role of STATs in transcriptional control and their impact on cellular function
Abstract
The STAT proteins (Signal Transducers and Activators of Transcription), were identified in the last decade as transcription factors which were critical in mediating virtually all cytokine driven signaling. These proteins are latent in the cytoplasm and become activated through tyrosine phosphorylation which typically occurs through cytokine receptor associated kinases (JAKs) or growth factor receptor tyrosine kinases. Recently a number of non-receptor tyrosine kinases (for example src and abl) have been found to cause STAT phosphorylation. Phosphorylated STATs form homo- or hetero-dimers, enter the nucleus and working coordinately with other transcriptional co-activators or transcription factors lead to increased transcriptional initiation. In normal cells and in animals, ligand dependent activation of the STATs is a transient process, lasting for several minutes to several hours. In contrast, in many cancerous cell lines and tumors, where growth factor dysregulation is frequently at the heart of cellular transformation, the STAT proteins (in particular Stats 1, 3 and 5) are persistently tyrosine phosphorylated or activated. The importance of STAT activation to growth control in experiments using anti-sense molecules or dominant negative STAT protein encoding constructs performed in cell lines or studies in animals lacking specific STATs strongly indicate that STATs play an important role in controlling cell cycle progression and apoptosis. Stat1 plays an important role in growth arrest, in promoting apoptosis and is implicated as a tumor suppressor; while Stats 3 and 5 are involved in promoting cell cycle progression and cellular transformation and preventing apoptosis. Many questions remain including: (1) a better understanding of how the STAT proteins through association with other factors increase transcription initiation; (2) a more complete definition of the sets of genes which are activated by different STATs and (3) how these sets of activated genes differ as a function of cell type. Finally, in the context of many cancers, where STATs are frequently persistently activated, an understanding of the mechanisms leading to their constitutive activation and defining the potential importance of persistent STAT activation in human tumorigenesis remains. Oncogene (2000).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 is also a key factor in inflammation, autoimmunity and cancer, with its effect mainly exerted through the IL-6–signal transducer and activator of transcription 3 (STAT3) pathway (18–26, 61–65).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [61]
In the citing paper
“HCV core protein interacts with the signal transducer and activator of transcription 3 (STAT3) protein36, a transcription factor involved in mediating cytokine signalling37.”
From Inflammation and cancer (2002) · cites this paper as [37]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,539
A Matter of Life and Cell Death
Evan, G. I., & Littlewood, T. D. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,528
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Stat3 upregulates MEK5 expression in human breast cancer cells
Song, H., Jin, X., & Lin, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208026 · Cited by 59
Percario, Z. A., Olivetta, E., Fiorucci, G., Mangino, G., Peretti, S., Romeo, G., Affabris, E., & Federico, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403161 · Cited by 59
Clinical, Pathological and Molecular Determinants in Squamous Cell Carcinoma of the Oral Cavity
Al-Swiahb, J. N., Chen, C., Chuang, H., Fang, F., Tasi, H.-T., & Chien, C. (2010) · Future Oncology · doi:10.2217/fon.10.35 · Cited by 59
Zhang, X., Liu, P., Zhang, B., Wang, A., & Yang, M. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.10.004 · Cited by 59
Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1
Hatzivassiliou, E. (2002) · Frontiers in bioscience · doi:10.2741/hatziva · Cited by 59
Fu, J., Chen, D., Zhao, B., Zhao, Z., Zhou, J., Xu, Y., Xin, Y., Liu, C., Luo, L., & Yin, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049194 · Cited by 59
Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development
Buettner, R., Corzano, R., Rashid, R., Lin, J., Senthil, M., Hedvat, M., Schroeder, A., Mao, A., Herrmann, A., Yim, J. H., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb100253e · Cited by 58
Stat3 modulates heat shock 27 kDa protein expression in breast epithelial cells
Song, H., Ethier, S. P., Dziubinski, M. L., & Lin, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.048 · Cited by 60
Lin, W., Zheng, L., Zhuang, Q., Zhao, J., Cao, Z., Zeng, J., Lin, S., Xu, W., & Peng, J. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-144 · Cited by 58
Page, B. D. G., Fletcher, S., Yue, P., Li, Z., Zhang, X., Sharmeen, S., Datti, A., Wrana, J. L., Trudel, S., Schimmer, A. D., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.056 · Cited by 58
Chen, H., Yang, Z., Ding, C., Xiong, A., Wild, C., Wang, L., Ye, N., Cai, G., Flores, R. M., Ding, Y., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.049 · Cited by 58
A novel target for treatment of chordoma: signal transducers and activators of transcription 3
Cao, Y., Schwab, J. H., Schoenfeld, A. J., Hornicek, F. J., Wood, K. B., Nielsen, G. P., Choy, E., Mankin, H. J., & Duan, Z. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0504 · Cited by 58
Kandala, P. K., & Srivastava, S. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-9 · Cited by 58
Jeong, S. K., Kim, J., Lee, C. G., Park, Y.-S., Kim, S., Yoon, S. O., Han, D. H., Lee, K. Y., Jeong, M. H., & Jo, W. S. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.11.010 · Cited by 58
Mandal, P. K., Limbrick, D., Coleman, D. R., Dyer, G. A., Ren, Z., Birtwistle, J. S., Xiong, C., Chen, X., Briggs, J. M., & McMurray, J. S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801491w · Cited by 59
Tarn, C., Zou, L., Hullinger, R. L., & ANDRISANI, O. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9763-9772.2002 · Cited by 59
Chang, T. L.-Y., Mosoian, A., Pine, R. I., Klotman, M. E., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.569-581.2002 · Cited by 58
STAT3 activation in microglia exacerbates hippocampal neuronal apoptosis in diabetic brains
Yun, J., Lee, D., Jeong, H., Kim, H. S., Ye, S., & Cho, C. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30373 · Cited by 57
Ozawa, Y., Williams, A. H., Estes, M. L., Matsushita, N., Boschelli, F., Jove, R., & List, A. F. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.11.032 · Cited by 57
Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3
Sherry-Lynes, M. M., Sengupta, S., Kulkarni, S., & Cochran, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174775 · Cited by 60
Severin, F., Frezzato, F., Visentin, A., Martini, V., Trimarco, V., Carraro, S., Tibaldi, E. V., Brunati, A. M., Piazza, F., Semenzato, G., et al. (2019) · Cancers · doi:10.3390/cancers11121939 · Cited by 59
Short Hairpin RNA-Mediated Fibronectin Knockdown Delays Tumor Growth in a Mouse Glioma Model
Sengupta, S., Nandi, S., Hindi, E. S., Wainwright, D. A., Han, Y., & Lesniak, M. S. (2010) · Neoplasia · doi:10.1593/neo.10662 · Cited by 59
Kang, Z., Zhang, S., He, L., Zhu, H., Wang, Z., Yan, H., Huang, Y., Dang, R., Lei, C., Chen, H., et al. (2019) · Theriogenology · doi:10.1016/j.theriogenology.2019.07.026 · Cited by 55
Polymerization in living organisms
Wu, D., Lei, J., Zhang, Z., Huang, F., Buljan, M., & Yu, G. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00759b · Cited by 56
Shi, T., Wang, J., Dong, J., Hu, P., & Guo, Q. (2023) · Pathogens · doi:10.3390/pathogens12091110 · Cited by 55
Sun, Y., Yang, S., Sun, N., & Chen, J. (2014) · Pancreas · doi:10.1097/mpa.0000000000000074 · Cited by 55
Kim, H., Lee, T., Hwang, Y. S., Bang, M. A., Kim, K. H., Suh, J. M., Chung, H. K., Yu, D., Lee, K.-K., Kwon, O., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.5.972 · Cited by 55
Shibata, R., Kai, H., Seki, Y., Kato, S., Wada, Y., Hanakawa, Y., Hashimoto, K., Yoshimura, A., & Imaizumi, T. (2003) · Human Gene Therapy · doi:10.1089/104303403321618128 · Cited by 56
Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line
Fujimoto, E., Sato, H., Shirai, S., Nagashima, Y., Fukumoto, K., Hagiwara, H., Negishi, E., Ueno, K., Omori, Y., Yamasaki, H., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208430 · Cited by 55
Barton, B. E., Murphy, T. F., Shu, P., Huang, H. F. S., Meyenhofen, M., & Barton, A. B. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1183.3.10 · Cited by 55
Streetz, K. L., Fregien, B., Plümpe, J., Koerber, K., Kubicka, S., Sass, G., Bischoff, S. C., Manns, M. P., Tiegs, G., & Trautwein, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.514 · Cited by 55
Yang, X. (2007) · Frontiers in bioscience · doi:10.2741/2775 · Cited by 55
Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer
Nefedova, Y., & Gabrilovich, D. I. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006887 · Cited by 54
Ion-current-based Proteomic Profiling of the Retina in a Rat Model of Smith-Lemli-Opitz Syndrome
Tu, C., Li, J., Jiang, X.-S., Sheflin, L. G., Pfeffer, B. A., Behringer, M. D., Fliesler, S. J., & Qu, J. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.027847 · Cited by 54
Li, J., Zhang, L., Zhang, J., Wei, Y., Li, K., Huang, L., Zhang, S., Gao, B., Wang, X., & Lin, P. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs384 · Cited by 54
IFN-λ Cancer Immunotherapy: New Kid on the Block
Lasfar, A., Gogas, H. J., Zloza, A., Kaufman, H. L., & Kirkwood, J. M. (2016) · Immunotherapy · doi:10.2217/imt-2015-0021 · Cited by 54
Han, X., Wang, L., Li, T., Zhang, J., Zhang, D., Li, J., Xia, Y., Liu, Y., & Tan, W. (2020) · ACS Nano · doi:10.1021/acsnano.0c08022 · Cited by 54
Poh, A. R., & Ernst, M. (2023) · Oncogene · doi:10.1038/s41388-023-02701-x · Cited by 54
Peng, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1326 · Cited by 54
Gunning, P. T., Katt, W. P., Glenn, M. P., Siddiquee, K., Kim, J. S., Jove, R., Sebti, S. M., Turkson, J., & Hamilton, A. D. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.077 · Cited by 53
Lin, J., Li, Q., Chen, H., Lin, H., Lai, Z., & Peng, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.2956 · Cited by 53
Rosas, L. E., Snider, H. M., Barbi, J. J., Satoskar, A. A., Lugo‐Villarino, G., Keiser, T. L., Papenfuss, T. L., Durbin, J. E., Radzioch, D., Glimcher, L. H., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.22 · Cited by 53
Ataxia Telangiectasia Mutated Proteins, MAPKs, and RSK2 Are Involved in the Phosphorylation of STAT3
Zhang, Y., Cho, Y., Petersen, B. L., Bode, A. M., Zhu, F., & Dong, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210368200 · Cited by 55
Dicitore, A., Caraglia, M., Gaudenzi, G., Manfredi, G. I., Amato, B., Mari, D., Persani, L., Arra, C., & Vitale, G. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.11.003 · Cited by 52
Epstein–Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration
Banerjee, A. S., Pal, A. D., & Banerjee, S. (2013) · Virology · doi:10.1016/j.virol.2013.05.020 · Cited by 52
Building Cell Selectivity into CPP-Mediated Strategies
Martín, I., Teixidò, M., & Giralt, E. (2010) · Pharmaceuticals · doi:10.3390/ph3051456 · Cited by 53
Heidelberger, S., Zinzalla, G., Antonow, D., Essex, S., Piku Basu, B., Palmer, J., Husby, J., Jackson, P. J. M., Rahman, K. M., Wilderspin, A. F., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.066 · Cited by 52
Patterson, K. A., Zhang, X., Wrobleski, S. K., Hawley, A. E., Lawrence, D. A., Wakefield, T. W., Myers, D. D., & Diaz, J. A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.12.006 · Cited by 52
Antagonism of the Stat3–Stat3 Protein Dimer with Salicylic Acid Based Small Molecules
Fletcher, S., Page, B. D. G., Zhang, X., Yue, P., Li, Z. H., Sharmeen, S., Singh, J., Zhao, W. M., Schimmer, A. D., Trudel, S., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100194 · Cited by 52
Long noncoding RNA H19 competitively binds miR‐93‐5p to regulate STAT3 expression in breast cancer
Li, J., Xiang, Y., Fan, L., Yao, A., Li, H., & Liao, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27578 · Cited by 52
Maresin1 ameliorates acute lung injury induced by sepsis through regulating Th17/Treg balance
Xia, H., Wang, F., Wang, M., Wang, J., Sun, S., Chen, M., Huang, S., Chen, X., & Yao, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117773 · Cited by 52
Trevino, J. G., Gray, M. J., Nawrocki, S. T., Summy, J. M., Lesslie, D. P., Evans, D. B., Sawyer, T. K., Shakespeare, W. C., Watowich, S. S., Chiao, P. J., et al. (2006) · Angiogenesis · doi:10.1007/s10456-006-9038-9 · Cited by 52
Huang, H. F. S., Murphy, T. F., Shu, P., Barton, A. B., & Barton, B. E. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-2 · Cited by 52
Stat3 Is Required for Cytoprotection of the Respiratory Epithelium during Adenoviral Infection
Matsuzaki, Y., Xu, Y., Ikegami, M., Besnard, V., Park, K.-S., Hull, W. M., Wert, S. E., & Whitsett, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.527 · Cited by 51
Jokela, T. A., Kärnä, R., Makkonen, K. M., Laitinen, J. T., Tammi, R., & Tammi, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551804 · Cited by 51
Targeting Multiple Key Signaling Pathways in Melanoma Using Leelamine
Gowda, R., Madhunapantula, S. V., Kuzu, O. F., Sharma, A. K., & Robertson, G. P. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0867 · Cited by 51
HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
Togi, S., Kamitani, S., Kawakami, S., Ikeda, O., Muromoto, R., Nanbo, A., & Matsuda, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.132 · Cited by 52
Identification of STAT-1 as a Molecular Target of IGFBP-3 in the Process of Chondrogenesis
Spagnoli, A., Torello, M., Nagalla, S. R., Horton, W. A., Pattee, P., Hwa, V., Chiarelli, F., Roberts, C. T., & Rosenfeld, R. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200218200 · Cited by 51
Epidermal growth factor receptor directed therapy in head and neck cancer
Choong, N. W., & Cohen, E. E. W. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.06.002 · Cited by 52
Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents
Youlyouz‐Marfak, I., Gachard, N., Clorennec, C. L., Najjar, I., Baran‐Marszak, F., Reminieras, L., May, E., Bornkamm, G. W., Fagard, R., & Feuillard, J. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402270 · Cited by 50
STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?
Jr., R. H. B. (2009) · CRC Press eBooks · doi:10.1201/9781498713764-13 · Cited by 50
Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line
Chichiarelli, S., Gaucci, E., Ferraro, A., Grillo, C., Fabio Altieri, F., Cocchiola, R., Arcangeli, V., Turano, C., & Eufemi, M. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.12.004 · Cited by 50
Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase
Sarcar, B., Ghosh, A. K., Steele, R., RAY, R. K., & Ray, R. B. (2004) · Virology · doi:10.1016/j.virol.2004.01.008 · Cited by 50
IL-4 synergistically enhances both IL-2– and IL-12–induced IFN-γ expression in murine NK cells
Bream, J. H., Curiel, R. E., Yu, C., Egwuagu, C. E., Grusby, M. J., Aune, T. M., & Young, H. A. (2003) · Blood · doi:10.1182/blood-2002-08-2602 · Cited by 50
CPAP Is a Novel Stat5-Interacting Cofactor that Augments Stat5-Mediated Transcriptional Activity
Peng, B. H., Sutherland, K. D., Sum, E. Y. M., Olayioye, M. A., Wittlin, S., Tang, T. K., Lindeman, G. J., & Visvader, J. E. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0108 · Cited by 51
Ni, J., Shen, Y., Wang, Z., Shao, D., Liu, J., Kong, Y.-L., Fu, L., Zhou, L., Xue, H., Huang, Y., et al. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.54 · Cited by 49
Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b
Shipley, J. M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.020 · Cited by 49
Mitchell, T. J., Whittaker, S. J., & John, S. (2003) · PubMed · Cited by 49
Ekmekçioglu, S., Ellerhorst, J. A., Mumm, J. B., Zheng, M., Broemeling, L. D., Prieto, V. G., Stewart, A. L., Mhashilkar, A. M., Chada, S., & Grimm, E. A. (2003) · PubMed · Cited by 49
Wang, X., Zhang, Y., ZHANG, X., Tian, W., Feng, W., & Chen, T. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1298 · Cited by 49
Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression
Suman, P., Poehlmann, T. G., Prakash, G. J., Markert, U. R., & Sk, G. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.07.002 · Cited by 48
STAT1 negatively regulates hepatocellular carcinoma cell proliferation
CHEN, G., Wang, H., Xie, S., Ma, J., & Wang, G. (2013) · Oncology Reports · doi:10.3892/or.2013.2398 · Cited by 48
Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation
Carpi, A., Nicolini, A., Antonelli, A., Ferrari, P., & Rossi, G. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909790192392 · Cited by 49
Echarri, M. J., Martín, A. L., & Hitt, R. (2016) · Cancers · doi:10.3390/cancers8030027 · Cited by 48
Novel Carbazole Inhibits Phospho-STAT3 through Induction of Protein–Tyrosine Phosphatase PTPN6
Hou, S., Yi, Y. W., Kang, H. J., Zhang, L., Kim, H. J., Kong, Y., Liu, Y., Wang, K., Kong, H., Grindrod, S. C., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4018042 · Cited by 48
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 49
Hückel, M., Schurigt, U., Wagner, A. H., Stöckigt, R., Petrow, P. K., Thoss, K., Gajda, M. R., Henzgen, S., Hecker, M., & Bräuer, R. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1869 · Cited by 48
Determination of leptin signaling pathways in human and murine keratinocytes
Goren, I., Pfeilschifter, J. M., & Frank, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00480-7 · Cited by 48
Verma, N. K., Davies, A. M., Long, A., Kelleher, D. P., & Volkov, Y. (2010) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-010-0008-2 · Cited by 49
Pramanik, R., Jørgensen, T. N., Xin, H., Kotzin, B. L., & Choubey, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313140200 · Cited by 48
STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression
Joo, A., Aburatani, H., Morii, E., Iba, H., & Yoshimura, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207174 · Cited by 48
Activation of transcription factors by drugs inducing oxidative stress in rat liver
Tacchini, L., Fusar-Poli, D., & Bernelli‐Zazzera, A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00836-x · Cited by 48
Mahata, B., Cabrera, A., Brenner, D. A., Guerra-Resendez, R. S., Li, J., Goell, J., Wang, K., Guo, Y., Escobar, M., Parthasarathy, A. K., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-02036-1 · Cited by 47
STAT3 regulated ATR via microRNA-383 to control DNA damage to affect apoptosis in A431 cells
Liao, X., Zheng, L., He, H., Zheng, D., Wei, Z., Wang, N., Dong, J., Ma, W., & Zhang, T. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.08.005 · Cited by 48
Jain, S. K., Wei, J., Mitrani, L. R., & Bishopric, N. H. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2069-6 · Cited by 48
Xiao, H., Bid, H. K., Chen, X. '., Wu, X., Wei, J., Bian, Y., Zhao, C., Li, H., Li, C., & Lin, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180297 · Cited by 47
Liu, Z., Meng, J., Li, X., Zhu, F., Liu, T., Wu, G., & Zhang, L. (2018) · BioMed Research International · doi:10.1155/2018/3574534 · Cited by 47
Bolaños-García, V. M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3696-6 · Cited by 47
STAT3 is activated in a subset of the Ewing sarcoma family of tumours
Lai, R. L., Navid, F., Galindo, C. R., Liu, T., Fuller, C., Ganti, R., Dien, J., Dalton, J., Billups, C. A., & Khoury, J. (2006) · The Journal of Pathology · doi:10.1002/path.1941 · Cited by 47
Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1
Zhang, Y. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh115 · Cited by 48
Glucose induced MAPK signalling influences NeuroD1‐mediated activation and nuclear localization
Petersen, H. V., Jensen, J. N., Stein, R. W., & Serup, P. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03318-5 · Cited by 47
Loss of oncostatin M receptor β in metastatic melanoma cells
Lacreusette, A., Nguyen, J., Pandolfino, M., Khammari, A., Dréno, B., Jacques, Y., Godard, A., & Blanchard, F. (2006) · Oncogene · doi:10.1038/sj.onc.1209844 · Cited by 47
Resetca, D., Haftchenary, S., Gunning, P. T., & Wilson, D. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595454 · Cited by 47
Rhee, K. D., Wang, Y., ten Hoeve, J., Stiles, L., Nguyen, T. T. T., Zhang, X., Vergnes, L., Reue, K., Shirihai, O. S., Bok, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34443-x · Cited by 47
Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules
Zhang, W., Ma, T., Li, S., Yang, Y., Guo, J., Yu, W., & Kong, L. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.068 · Cited by 46
Wu, J., Tang, Q., Yang, L., Chen, Y., Zheng, F., & Hann, S. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00626-6 · Cited by 47
Gatta, L. B., Melocchi, L., Bugatti, M., Missale, F., Lonardi, S., Zanetti, B., Cristinelli, L., Belotti, S., Simeone, C., Ronca, R., et al. (2019) · Cancers · doi:10.3390/cancers11091219 · Cited by 46
Dien, J., Amin, H. M., Chiu, N., Wong, W., Frantz, C., Chiu, B., Mackey, J. R., & Lai, R. L. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051109 · Cited by 48
Interleukin 4 Regulates Phosphorylation of Serine 756 in the Transactivation Domain of Stat6
Wang, Y., Malabarba, M. G., Nagy, Z. S., & Kirken, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313668200 · Cited by 47
Shah, N. G., Trivedi, T. I., Tankshali, R. A., Goswami, J., Jetly, D., Kobawala, T. P., Shukla, S. N., Shah, P. M., & Verma, R. J. (2006) · The International Journal of Biological Markers · doi:10.1177/172460080602100307 · Cited by 47
Metadata
- Authors
- Bromberg, J., & Darnell, J. E.
- Affiliations
- Rockefeller University (US)
- ORCID
- Bromberg, Jacqueline
- Venue
- Oncogene
- Published
- 2000-05-25
- Volume
- 19
- Issue
- 21
- Pages
- 2468-2473
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977681992
- Cited by
- 1,201
- References
- 66
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 21 · 2023: 24 · 2022: 37 · 2021: 40 · 2020: 46 · 2019: 41 · 2018: 42 · 2017: 51 · 2016: 46 · 2015: 49 · 2014: 59 · 2013: 67 · 2012: 56
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT proteins, transcriptional regulation, cytokine signaling, JAK kinases, tyrosine phosphorylation, STAT1, STAT3, STAT5, cell cycle progression, apoptosis, tumor suppressor, cell transformation, carcinogenesis, transcriptional coactivator
- MeSH terms
- Animals, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Gene Expression Regulation, Humans, Milk Proteins, Neoplasms, Structure-Activity Relationship, Transcription, Genetic, Trans-Activators, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review